Hae

Metabolic disorders during pregnancy may challenge the mother and child to longterm health complications. Emerging data indicates a link between increased intestinal permeability and metabolic risk markers in a non-pregnant ...

Afferent lymphatic vessels transport leukocytes and soluble molecules from the periphery to lymph nodes. These vessels are lined with lymphatic endothelial cells (LEC), which are also present in lymph node sinuses. Lymph ...

Lyme borreliosis, the most common tick-borne disease in the northern hemisphere, is caused by Borrelia burgdorferi sensu lato spirochetes (later Borrelia). They can infect humans through bites of infected Ixodes ticks. If ...

Bladder cancer (BC) is a highly prevalent disease with wide variety in outcome. Non-muscle invasive tumors have good prognosis but are prone to recur and, furthermore, have a major risk of progression. Muscle-invasive ...

Secondary lymphoid organs, including lymph nodes (LNs) and the spleen, play an important role in protecting us against invading pathogens. While LNs are connected to lymphatic vessels and receive antigens from the peripheral ...

The gut microbiota has been suggested to be an important factor in the development of autoimmune diseases such as type 1 diabetes (T1D). Priming of islet specific T cells in the pancreatic lymph nodes (PaLN) and their ...

Somatic hypermutation (SHM) is an essential mechanism for the development of high-affinity antibodies. SHM occurs in germinal center B cells targeting antibody-coding immunoglobulin (Ig) genes to increase the affinity of ...

The immune system is our constant protector against external foes but also against our own incipient malignant cells. Unfortunately, developing cancers often learn to shut down the antitumor immune response or even to ...

Type 1 diabetes is a chronic autoimmune disease, in which insulin secreting beta cells in the pancreas are destroyed. The disease pathogenesis can be divided into an asymptomatic preclinical phase and symptomatic disease. ...

Carbapenemase-producing (CP) Enterobacterales (CPE) are a growing menace to healthcare systems worldwide. CPE infections are difficult to treat because few antimicrobials remain effective. One of the new drug combinations, ...